Negatu DA, Aragaw WW, Gebresilase TT, Paruchuri S, et al. Durlobactam to boost the clinical utility of standard of care beta-lactams against Mycobacterium abscessus lung disease. Antimicrob Agents Chemother 2025;69:e0104624.
PMID: 39565116